CD44v, S1PR1, HER3, MET and cancer‐associated amino acid transporters are promising targets for the pancreatic cancers characterized using mAb

CD44v, S1PR1, HER3, MET and cancer‐associated amino acid transporters are promising targets for the pancreatic cancers characterized using mAb

Effective therapies have yet to be established for pancreatic ductal adenocarcinomas (PDAC) even though it is the most aggressive cancer. In the present study, PDAC was analyzed using novel rat mAbs against membrane proteins in conjunction with flow cytometry and immunohistochemistry. Human epiderma...

Full description

Saved in:
Bibliographic Details
Main Authors: Takashi Nakano, Kouki Okita, Shogo Okazaki, Soshi Yoshimoto, Sachiko Masuko, Hideki Yagi, Kazunori Kato, Yoshihisa Tomioka, Kenichi Imai, Yoichi Hamada, Kazue Masuko, Kayoko Shimada‐Takaura, Noriaki Nagai, Hideyuki Saya, Tomio Arai, Toshiyuki Ishiwata, Takashi Masuko
Format: Article
Language:English
Published: Wiley 2025-05-01
Series:FEBS Open Bio
Subjects:
amino acid transporter
CD44v
HER3
MET
pancreatic cancer
S1PR1
Online Access:https://doi.org/10.1002/2211-5463.13963
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/2211-5463.13963

Similar Items